The therapeutic goals of essential thrombocythemia under the clouds of over-treatment and under-treatment

Haznedaroglu I. C.

EXPERT OPINION ON PHARMACOTHERAPY, vol.14, no.11, pp.1431-1436, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Editorial Material
  • Volume: 14 Issue: 11
  • Publication Date: 2013
  • Doi Number: 10.1517/14656566.2013.799140
  • Journal Name: EXPERT OPINION ON PHARMACOTHERAPY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1431-1436
  • Hacettepe University Affiliated: No

Abstract

Introduction: Therapeutic stratification after the accurate essential thrombocythemia (ET) diagnosis is made based on the medical history (age, previous thrombosis), clinical assessments (cardiovascular [CV] risk factors, comorbidities, systemic diseases), laboratory examinations (leukocytosis, extreme thrombocytosis, anemia) and if available further sophistical analyses (CD34 count, JAK2V617F homozygosity, and mutant allele burden).